Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002223 · ClinicalTrials.gov registry record · NA
A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
A NA study, sponsored by Abbott.
- Completed
- Registry status
- NA
- Development phase
NCT00002223 is a NA study that has completed, run by Abbott.
The verdict
NCT00002223, a NA study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination.
Interventions
- DRUG Ritonavir
- DRUG Indinavir sulfate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002223
The ClinicalTrials.gov registry entry for NCT00002223 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ritonavir is the first listed.
NCT00002223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002223 about?
NCT00002223 is a clinical study titled "A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients". The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination...
What is the current status of trial NCT00002223?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002223?
The interventions under investigation include: Ritonavir (DRUG), Indinavir sulfate (DRUG).
Who is sponsoring clinical trial NCT00002223?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.